Statistics notes. Treatment allocation in controlled trials: why randomise?

BMJ (Clinical research ed.) ·Vol. 318 ·No. 7192 ·1999-05-01 ·Pages 1209

Altman DG, Bland JM

Abstract

暂无摘要

MeSH Terms

Patient Selection Randomized Controlled Trials as Topic/methods

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Altman D G

ICRF Medical Statistics Group, Centre for Statistics in Medicine, Institute of Health Sciences, Oxford OX3 7LF.

Bland J M

References (7)

7 references, click to expand

STREPTOMYCIN treatment of pulmonary tuberculosis.
Br Med J. 1948 Oct 30;2(4582):769-82 PMID: 18890300
Randomized versus historical controls for clinical trials.
Am J Med. 1982 Feb;72(2):233-40 PMID: 7058834
Possible prevention of neural-tube defects by periconceptional vitamin supplementation.
Lancet. 1980 Feb 16;1(8164):339-40 PMID: 6101792
Improving the quality of reporting of randomized controlled trials. The CONSORT statement.
JAMA. 1996 Aug 28;276(8):637-9 PMID: 8773637
Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group.
Lancet. 1991 Jul 20;338(8760):131-7 PMID: 1677062
Randomisation.
BMJ. 1991 Jun 22;302(6791):1481-2 PMID: 1855013
Why we need observational studies to evaluate the effectiveness of health care.
BMJ. 1996 May 11;312(7040):1215-8 PMID: 8634569

Article Info

Journal

BMJ (Clinical research ed.)

Abbr.

BMJ

ISSN

0959-8138

DOI

Published

1999-05-01

Pages

1209

Language

English

Region

England

NLM ID

8900488

PMCID

PMC1115595

Subset

Corrections

CommentIn

PMID: 10496847

External Links

Analysis Services